- Home
- DRUG vs FSTR Comparison
DRUG vs FSTR Comparison
Compare DRUG & FSTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRUG
- FSTR
- Stock Information
- Founded
- DRUG 2019
- FSTR 1902
- Country
- DRUG United States
- FSTR United States
- Employees
- DRUG N/A
- FSTR N/A
- Industry
- DRUG Pharmaceuticals and Biotechnology
- FSTR Metal Fabrications
- Sector
- DRUG Health Care
- FSTR Industrials
- Exchange
- DRUG Nasdaq
- FSTR Nasdaq
- Market Cap
- DRUG 345.6M
- FSTR 285.6M
- IPO Year
- DRUG N/A
- FSTR N/A
- Fundamental
- Price
- DRUG $55.20
- FSTR $26.42
- Analyst Decision
- DRUG Strong Buy
- FSTR Hold
- Analyst Count
- DRUG 9
- FSTR 1
- Target Price
- DRUG $81.67
- FSTR $25.00
- AVG Volume (30 Days)
- DRUG 90.8K
- FSTR 26.6K
- Earning Date
- DRUG 08-11-2025
- FSTR 11-06-2025
- Dividend Yield
- DRUG N/A
- FSTR N/A
- EPS Growth
- DRUG N/A
- FSTR 395.33
- EPS
- DRUG N/A
- FSTR 3.32
- Revenue
- DRUG N/A
- FSTR $506,999,000.00
- Revenue This Year
- DRUG N/A
- FSTR $3.93
- Revenue Next Year
- DRUG N/A
- FSTR $4.51
- P/E Ratio
- DRUG N/A
- FSTR $7.84
- Revenue Growth
- DRUG N/A
- FSTR N/A
- 52 Week Low
- DRUG $0.94
- FSTR $17.16
- 52 Week High
- DRUG $79.02
- FSTR $29.78
- Technical
- Relative Strength Index (RSI)
- DRUG N/A
- FSTR N/A
- Support Level
- DRUG N/A
- FSTR N/A
- Resistance Level
- DRUG N/A
- FSTR N/A
- Average True Range (ATR)
- DRUG 0.00
- FSTR 0.00
- MACD
- DRUG 0.00
- FSTR 0.00
- Stochastic Oscillator
- DRUG 0.00
- FSTR 0.00
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
About FSTR L.B. Foster Company
L.B. Foster Co is a U.S-based firm engaged in the manufacturing, fabrication, and distribution of products and services, especially for the rail, construction, energy, and utility industries. The company operates its business through two segments: Rail Technologies and Services and Infrastructure Solutions. Its principal business activity involves providing new and used rail, trackwork, and accessories, producing concrete railroad ties, insulated rail joints, power rail, track fasteners, cover boards, and sales of sells and rents steel sheet piling, H-bearing pile, and other piling products for foundation and earth retention requirements. It generates the majority of its revenues from the Rail Technologies and Services segment.